A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to predict high or low risk of a breast cancer relapse. This is according to data presented today at ...

Cancer research is integral to advancing treatment options and developing cures for these diseases. With funding, resources, and collaboration, experts can improve their analysis and help patients.

The landmark NCI-MATCH precision medicine cancer trial continues to offer treatment opportunities. Two treatment arms are open while others are now closed to enrollment. Multiple journals are expected ...

Eastern Cooperative Oncology Group (ECOG) performance status (PS) is a key clinical variable for cancer treatment and research, but it is usually only recorded in unstructured form in the electronic ...